Drug · DIN 02234749
PMS-METHYLPHENIDATE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 24, 1997; first marketed October 24, 1997.
- Drug Identification Number (DIN)
- 02234749
- Company (DIN owner)
- Pharmascience Inc.Montreal, Quebec, Canada
- Schedule
- Controlled drugs (CDSA III)
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Methylphenidate N06BA04
- Class
- Human
- Record last updated
- June 29, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| METHYLPHENIDATE HYDROCHLORIDE | 5 MG |
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “pms-methylphenidate”. A notice may cover another product or only some lots: read it to see what it covers.
- PMS-Methylphenidate CR 10 mg capsule; exceed the acceptable intake limit for N-nitroso-methylphenidateJuly 4, 2025 · Drugs · Product quality · Type I
- pms-Méthylphénidate ER (2017-10-10)October 19, 2017 · Drugs · Product safety · Type II
Other DINs named PMS-METHYLPHENIDATE
- DIN 00584991 · Marketed
- DIN 00585009 · Marketed